WASHINGTON — Federal authorities say a Cincinnati-based company that provides prescription drugs for long-term care facilities agreed to pay the government more than $4 million to settle a whistle-blower lawsuit in South Carolina alleging the company engaged in illegal kickbacks.
The Justice Department said Thursday that the civil settlement resolves allegations that Omnicare solicited and received kickbacks from the California-based drug manufacturer Amgen Inc. in return for implementing programs designed to switch Medicaid beneficiaries from a competitor drug to Amgen’s Aranesp product.
The government says the alleged kickbacks included performance-based rebates, grants, consulting services and dinners. The government says the settlement involves claims and no liability was determined.
Omnicare didn’t immediately return a call for comment Thursday.
The company provides pharmaceuticals and services to long-term care facilities.
Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. Comments that violate these standards, or our privacy statement or visitor's agreement, are subject to being removed and commenters are subject to being banned. To post comments, you must be a registered user on toledoblade.com. To find out more, please visit the FAQ.